2C-I





2C-I

Systematic (IUPAC) name
2,5-Dimethoxy-4-iodophenethylamine
Identifiers
CAS number 69587-11-7
PubChem          ?
Chemical data
Formula O2 
Molar mass 307.13 g/mol
SMILES NCCC1=C(OC)C=C(I)C(OC)=C1
Physical data
Melt. point 246 °C
Complete data

2C-I is a tablet form.

Recreational use

In the early 2000s, 2C-I in powder form became available for purchase from several online vendors of tablets of 2C-I were being sold in nightclubs and at raves in Denmark and in the United Kingdom as a club drug[citation needed].

Effects

2C-I is generally taken orally, although it can also be insufflated, or administered rectally as well (though 2C-I often causes considerable pain upon insufflation). There have also been a few reports of intramuscular and intravenous injections. An oral recreational dose of 2C-I is commonly between 10mg and 25mg, although doses as low as 2mg have been reported to be active. The onset of effects usually occurs within an hour, and the effects of the drug typically last somewhere in the range of 5 to 12 hours. The effects of the drug are often described as quite similar to those of its chemical relative 2C-T-7.

Side effects

  Virtually no research has been conducted on the toxicity of 2C-I. No deaths have been attributed to the drug. There have been no reports of physical dependence or addiction. Comparisons with similar compounds suggest that use of 2C-I is unlikely to result in physical dependence.

Law

2C-I is an illegal, controlled substance in several European nations, including Denmark, Germany, Greece, Ireland, and the United Kingdom. In December 2003, the European Council issued a binding order compelling all EU member states to ban 2C-I within three months. 2C-I is unscheduled and unregulated in the United States, however its close similarity in structure and effects to Operation Web Tryp.

See also

Categorization

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "2C-I". A list of authors is available in Wikipedia.